Skip to Content

MYLAN 233 (Efavirenz 600 mg)

Pill imprint MYLAN 233 has been identified as Efavirenz 600 mg.

Efavirenz is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class NNRTIs. There is positive evidence of human fetal risk during pregnancy. Efavirenz 600 mg is not a controlled substance under the Controlled Substance Act (CSA).

Efavirenz
Imprint:
MYLAN 233
Strength:
600 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
NNRTIs
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide